Venetoclax combined with daunorubicin and cytarabine (2+6) in acute myeloid leukemia: Updated results of a phase II trial

被引：0

作者：

Suo, Xiaohui ^{[1
]}

Fang, Zheng ^{[2
]}

Wang, Dongmei ^{[3
]}

Zhao, Liyun ^{[4
]}

Liu, Jie ^{[5
]}

Li, Hong ^{[6
]}

Ma, Xiaojun ^{[1
]}

Zhang, Congcong ^{[1
]}

Zhao, Xuemei ^{[2
]}

Shi, Rui ^{[3
]}

Wu, Yan ^{[3
]}

Jiao, Zongjiu ^{[4
]}

Song, Jiaojie ^{[4
]}

Zhang, Ling ^{[5
]}

Li, Ling ^{[7
]}

Zhang, Suping ^{[8
]}

Lu, Xinxiao ^{[9
]}

Yuan, Linyu ^{[9
]}

Gao, Sifeng ^{[10
]}

Zhang, Jilei ^{[10
]}

Liu, Kaiqi ^{[11
]}

Zhao, Xingli ^{[9
]}

Bai, Guanchen ^{[10
]}

Mi, Yingchang ^{[11
]}

机构：

[1] Handan Cent Hosp, Dept Hematol, Handan, Hebei, Peoples R China

[2] Second Peoples Hosp Guiyang, Dept Hematol, Guiyang, Guizhou, Peoples R China

[3] Harrison Int Peace Hosp, Dept Hematol, Hengshui, Hebei, Peoples R China

[4] People Hosp XingTai, Dept Hematol, Xing Tai, Hebei, Peoples R China

[5] Sinopharm Tongmei Gen Hosp, Dept Hematol, Datong, Shanxi, Peoples R China

[6] Daqing Oilfied Gen Hosp, Dept Hematol, Daqing, Heilongjiang, Peoples R China

[7] Inner Mongolia Peoples Hosp, Dept Hematol, Hohhot, Neimenggu, Peoples R China

[8] Zhengzhou Univ, Dept Hematol, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China

[9] Tianjin Peoples Hosp, Oncol Ctr, Dept Hematol, Tianjin, Peoples R China

[10] Qingdao Univ, Dept Hematol, Affiliated Taian City Cent Hosp, Tai An, Shandong, Peoples R China

[11] Chinese Acad Med Sci & Peking Union Med Coll, Inst Hematol & Blood Dis Hosp, Natl Clin Res Ctr Blood Dis, State Key Lab Expt Hematol,Haihe Lab Cell Ecosyst, Tianjin, Peoples R China

来源：

HEMATOLOGICAL ONCOLOGY | 2024年 / 42卷 / 04期

基金：

中国国家自然科学基金;

关键词：

SINGLE-ARM; CHEMOTHERAPY;

D O I：

10.1002/hon.3296

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：4

共 50 条

[1] Venetoclax Combined with Daunorubicin and Cytarabine (2+6) in Acute Myeloid Leukemia: Updated Results of a Phase II Trial
Suo, Xiaohui
Wang, Dongmei
Zheng, Fang
Zhang, Suping
Zhang, Congcong
Li, Yinling
Shi, Rui
Wu, Yan
Yang, Sisi
Zhao, Liyun
Jiao, Zongjiu
Liu, Jie
Zhang, Ling
Li, Ling
Zhang, Zhihua
Lu, Xinxiao
Yuan, Linyu
Gao, Sifeng
Zhang, Jilei
Zhao, Xingli
Bai, Guanchen
Mi, Yingchang
Liu, Kaiqi
BLOOD, 2023, 142
[2] Venetoclax combined with daunorubicin and cytarabine (2+6) as induction treatment in adults with newly diagnosed acute myeloid leukemia: a phase 2, multicenter, single-arm trial
Suo, Xiaohui
Zheng, Fang
Wang, Dongmei
Zhao, Liyun
Liu, Jie
Li, Ling
Zhang, Zhihua
Zhang, Congcong
Li, Yinling
Yang, Sisi
Zhao, Xuemei
Shi, Rui
Wu, Yan
Jiao, Zongjiu
Song, Jiaojie
Zhang, Ling
Lu, Xinxiao
Yuan, Linyu
Gao, Sifeng
Zhang, Jilei
Zhao, Xingli
Bai, Guanchen
Liu, Kaiqi
Mi, Yingchang
EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2023, 12 (01)
[3] Venetoclax combined with daunorubicin and cytarabine (2 + 6) as induction treatment in adults with newly diagnosed acute myeloid leukemia: a phase 2, multicenter, single-arm trial
Xiaohui Suo
Fang Zheng
Dongmei Wang
Liyun Zhao
Jie Liu
Ling Li
Zhihua Zhang
Congcong Zhang
Yinling Li
Sisi Yang
Xuemei Zhao
Rui Shi
Yan Wu
Zongjiu Jiao
Jiaojie Song
Ling Zhang
Xinxiao Lu
Linyu Yuan
Sifeng Gao
Jilei Zhang
Xingli Zhao
Guanchen Bai
Kaiqi Liu
Yingchang Mi
Experimental Hematology & Oncology, 12
[4] Venetoclax Combined with Daunorubicin and Cytarabine (DAV) As Induction Therapy in De Novo Young Adult Acute Myeloid Leukemia
Wang, Huafeng
Mao, Liping
Xie, Wanzhuo
Tong, Hongyan
Yang, Min
Xu, Gaixiang
Ye, Xiujin
Lu, Ying
Wei, Juying
Mai, Wenyuan
Zhou, De
Jin, Jie
Zhu, Hong-Hu
BLOOD, 2021, 138
[5] Updated Results of a Randomized Phase II Trial of Idarubicin and Cytarabine with Clofarabine or Fludarabine in Patients with Newly Diagnosed Acute Myeloid Leukemia
Short, Nicholas J.
Ravandi, Farhad
Huang, Xuelin
Cortes, Jorge E.
Pemmaraju, Naveen
Daver, Naval
Khouri, Rita B.
Borthakur, Gautam
Jain, Nitin
Konopleva, Marina
Estrov, Zeev
Garcia-Manero, Guillermo
Kadia, Tapan M.
Wierda, William G.
DiNardo, Courtney D.
O'Brien, Susan M.
Shah, Syed
Pike, Allison
Brandt, Mark
Kantarjian, Hagop M.
Jabbour, Elias J.
BLOOD, 2016, 128 (22)
[6] Phase II trial of cytarabine and mitoxantrone with devimistat in acute myeloid leukemia
Rebecca Anderson
Lance D. Miller
Scott Isom
Jeff W. Chou
Kristin M. Pladna
Nathaniel J. Schramm
Leslie R. Ellis
Dianna S. Howard
Rupali R. Bhave
Megan Manuel
Sarah Dralle
Susan Lyerly
Bayard L. Powell
Timothy S. Pardee
Nature Communications, 13
[7] Phase II trial of cytarabine and mitoxantrone with devimistat in acute myeloid leukemia
Anderson, Rebecca
Miller, Lance D.
Isom, Scott
Chou, Jeff W.
Pladna, Kristin M.
Schramm, Nathaniel J.
Ellis, Leslie R.
Howard, Dianna S.
Bhave, Rupali R.
Manuel, Megan
Dralle, Sarah
Lyerly, Susan
Powell, Bayard L.
Pardee, Timothy S.
NATURE COMMUNICATIONS, 2022, 13 (01)
[8] Venetoclax Combined With Low-Dose Cytarabine for Previously Untreated Patients With Acute Myeloid Leukemia: Results From a Phase Ib/II Study
Wei, Andrew H.
Strickland, Stephen A., Jr.
Hou, Jing-Zhou
Fiedler, Walter
Lin, Tara L.
Walter, Roland B.
Enjeti, Anoop
Tiong, Ing Soo
Savona, Michael
Lee, Sangmin
Chyla, Brenda
Popovic, Relja
Salem, Ahmed Hamed
Agarwal, Suresh
Xu, Tu
Fakouhi, Kaffa M.
Humerickhouse, Rod
Hong, Wan-Jen
Hayslip, John
Roboz, Gail J.
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15) : 1277 - +
[9] Ten-Day Decitabine with Venetoclax (DEC10-VEN) in Acute Myeloid Leukemia: Updated Results of a Phase II Trial
Maiti, Abhishek
DiNardo, Courtney D.
Rausch, Caitlin R.
Cortes, Jorge E.
Pemmaraju, Naveen
Daver, Naval G.
Ravandi, Farhad
Garcia-Manero, Guillermo
Borthakur, Gautam M.
Naqvi, Kiran
Ohanian, Maro N.
Short, Nicholas J.
Alvarado, Yesid
Benton, Christopher B.
Kadia, Tapan M.
Takahashi, Koichi
Yilmaz, Musa E.
Jain, Nitin
Kornblau, Steven M.
Sasaki, Koji
Andreeff, Michael
Bose, Prithviraj
Ferrajoli, Alessandra
Issa, Ghayas C.
Jabbour, Elias
Masarova, Lucia
Rytting, Michael E.
Thompson, Philip A.
Wang, Sa A.
Konoplev, Sergej
Chen, Zhining
Goswami, Maitrayee
Maduike, Rita
Guerrero, Julio A.
Zhang, Qi
Cavazos, Antonio
Ma, Helen
Bivins, Carol A.
Wade, Allison
Adewale, Shadiat L.
Tse, Susan
Thomas, Robin
Vaughan, Kenneth
Pierce, Sherry A.
Ning, Jing
Qiao, Wei
Welch, John S.
Kantarjian, Hagop M.
Konopleva, Marina Y.
BLOOD, 2019, 134
[10] Cladribine with Low Dose Cytarabine and Venetoclax Alternated with Azacytidine and Venetoclax for Acute Myeloid Leukemia: Prognostic Analysis of a Phase 2 Clinical Trial
Bataller, Alex
Bazinet, Alexandre
Borthakur, Gautam
Short, Nicholas J.
Jabbour, Elias
Takahashi, Koichi
Daver, Naval
Issa, Ghayas C.
DiNardo, Courtney D.
Pemmaraju, Naveen
Jain, Nitin
Montalban-Bravo, Guillermo
Wierda, William G.
Garcia-Manero, Guillermo
Ravandi, Farhad
Kantarjian, Hagop M.
Kadia, Tapan M.
BLOOD, 2023, 142

← 1 2 3 4 5 →